Plasma-derived medicines and cell therapies across immunology, hematology, and critical care
Octapharma Austria is the Vienna-based manufacturing and R&D hub of a global plasma fractionation company operating across 120 countries. The tech stack reflects a highly regulated, capital-intensive operation: SAP for ERP, Veeva for pharma compliance, Kinaxis for supply-chain planning, alongside manufacturing control systems (PLC, SCADA, DCS) and enterprise cloud (AWS, Azure). Active hiring is concentrated in engineering and quality roles at senior levels, while projects center on capacity expansion, IT infrastructure modernization, and process harmonization — indicating a company scaling manufacturing footprint while tightening global governance and security controls.
Notable leadership hires: Team Lead, QC Shift Lead, Project Director
Octapharma Austria manufactures life-saving plasma-derived therapies and cell-line products for patients in immunology, hematology, and intensive care. The Vienna facility is the group's largest production site, housing the full value chain from R&D through manufacturing and support functions, employing over 1,700 staff across 50 nationalities. The company operates seven R&D centers, five production plants across Austria, France, Germany, and Sweden, and over 200 plasma donation centers in Europe and North America. Current priorities include greenfield capacity expansion, technology transfer projects, IT infrastructure strategy rollout, and global process standardization — all while maintaining compliance with pharmaceutical safety and quality regulations.
Plasma-derived medicines and cell therapies across three therapeutic areas: immunotherapy, hematology, and intensive care. Products are supplied to patients in 120 countries.
Austria, Sweden, and France. These align with the company's manufacturing footprint across Central and Western Europe.
Other companies in the same industry, closest in size